Branford, CT, United States of America

Alan A Divo

This inventor holds 2 USPTO granted patents. Top assignee: Yale University. Active years: 1992-1993.


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 2

Forward Citations = 11(Granted Patents)


Company Filing History:


Years Active: 1992-1993

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Alan A Divo: Innovator in Antineoplastic Agents

Introduction

Alan A Divo is a notable inventor based in Branford, CT (US). He has made significant contributions to the field of medicinal chemistry, particularly in the development of antineoplastic agents. With a total of 2 patents, his work focuses on innovative compounds that have the potential to treat cancer effectively.

Latest Patents

Divo's latest patents include groundbreaking research on sulfonylhydrazines and their use as antineoplastic agents. One of his patents details sulfonylhydrazines of the formula RSO.sub.2 N(CH.sub.2 CH.sub.2 X)N(SO.sub.2 CH.sub.3).sub.2, where R represents an alkyl or aryl group, and X is a halogen or OSO.sub.2 Y, with Y also being an alkyl or aryl. These compounds are particularly useful in cancer treatment, showcasing Divo's commitment to advancing medical science.

Career Highlights

Throughout his career, Alan A Divo has been associated with Yale University, where he has contributed to various research initiatives. His work has not only led to patents but has also paved the way for further studies in the field of oncology.

Collaborations

Divo has collaborated with esteemed colleagues such as Alan C Sartorelli and Krishnamurthy Shyam. These partnerships have enhanced his research and contributed to the development of innovative therapeutic agents.

Conclusion

Alan A Divo's contributions to the field of antineoplastic agents highlight his role as a significant inventor in medicinal chemistry. His innovative work continues to inspire advancements in cancer treatment.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…